Home LiteratureArticle Details
PMID: 1259577 Published · ppublish English Journal Article

The spectrum of pulmonary embolism: twenty years later.

Archives of surgery (Chicago, Ill. : 1960) ·Vol. 111 ·No. 4 ·1976-04-00 ·Pages 398-402

Coon WW

Abstract

A ten-year analysis of the prevalence of pulmonary embolism found at autopsy examination has been repeated 20 years after a prior study. The frequency of all pulmonary embolism (12.3%) and of "major" pulmonary emboli (7.1%) remains essentially unchanged from that detected 20 years previously (13.6% and 8.6%). Less than 10% of patients had the clinical diagnosis of deep leg vein thrombosis, and only 9.3% had a definitive diagnosis of pulmonary embolism made during life. A sixfold variation in quarterly frequency and a twofold variation in annual prevalence were noted. Since these wide fluctuations in frequency are present, any assumptions regarding a changing disease pattern must be made with great caution. There is no evidence that fatal pulmonary embolism has decreased in frequency in recent years. An effort should be made to increase rate of detection of thromboembolic disease by more widespread use of one or more of the recently developed diagnostic procedures, or a larger segment of the hospital population at risk should receive prophylactic therapy with "low-dose" heparin sodium.

MeSH Terms
Autopsy Coronary Disease/complications Demography Michigan Pulmonary Embolism/diagnosis,epidemiology,etiology Retrospective Studies Thrombophlebitis/etiology
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Coon W W
Article Info
Journal
Archives of surgery (Chicago, Ill. : 1960)
Abbr.
Arch Surg
ISSN
0004-0010
Published
1976-04-00
Pages
398-402
Language
English
Region
United States
NLM ID
9716528
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com